Stryker Co. (NYSE:SYK)‘s stock had its “hold” rating reiterated by equities researchers at Needham & Company LLC in a research note issued on Thursday, Marketbeat reports.

In related news, Director Ronda E. Stryker sold 6,000 shares of the stock in a transaction on Wednesday, November 18th. The stock was sold at an average price of $96.62, for a total transaction of $579,720.00. Following the completion of the sale, the director now directly owns 183,694 shares in the company, valued at $17,748,514.28. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 12,000 shares of the stock in a transaction on Friday, January 29th. The stock was sold at an average price of $98.12, for a total value of $1,177,440.00. Following the sale, the director now owns 192,194 shares of the company’s stock, valued at $18,858,075.28. The disclosure for this sale can be found here.

Several other analysts have also recently commented on the company. Deutsche Bank raised their target price on Stryker from $107.00 to $113.00 and gave the company a “buy” rating in a research report on Wednesday, January 27th. Canaccord Genuity reaffirmed a “buy” rating and set a $112.00 price target on shares of Stryker in a research note on Wednesday, January 27th. Brean Capital raised Stryker from a “hold” rating to a “buy” rating and set a $115.00 price target for the company in a research note on Wednesday, January 27th. Northland Securities lowered Stryker from an “outperform” rating to a “market perform” rating in a research note on Thursday, January 7th. Finally, Zacks Investment Research lowered Stryker from a “buy” rating to a “hold” rating in a research note on Tuesday, December 29th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $107.53.

Several hedge funds have recently made changes to their positions in SYK. Shelton Capital Management raised its stake in shares of Stryker by 11.3% in the fourth quarter. Shelton Capital Management now owns 3,930 shares of the medical technology company’s stock valued at $365,000 after buying an additional 400 shares in the last quarter. Plante Moran Financial Advisors LLC raised its stake in shares of Stryker by 1.7% in the fourth quarter. Plante Moran Financial Advisors LLC now owns 29,052 shares of the medical technology company’s stock valued at $2,700,000 after buying an additional 491 shares in the last quarter. World Asset Management Inc raised its stake in shares of Stryker by 2.7% in the fourth quarter. World Asset Management Inc now owns 34,736 shares of the medical technology company’s stock valued at $3,228,000 after buying an additional 916 shares in the last quarter. Roffman Miller Associates Inc. PA raised its stake in shares of Stryker by 4.3% in the fourth quarter. Roffman Miller Associates Inc. PA now owns 124,679 shares of the medical technology company’s stock valued at $11,588,000 after buying an additional 5,084 shares in the last quarter. Finally, Baltimore Washington Financial Advisors Inc. raised its stake in shares of Stryker by 87.0% in the fourth quarter. Baltimore Washington Financial Advisors Inc. now owns 54,256 shares of the medical technology company’s stock valued at $5,042,000 after buying an additional 25,235 shares in the last quarter.

Stryker (NYSE:SYK) traded up 0.02% during trading on Thursday, reaching $99.17. The company had a trading volume of 2,575,792 shares. The company has a 50-day moving average price of $92.48 and a 200 day moving average price of $96.72. The stock has a market cap of $37.12 billion and a PE ratio of 26.24. Stryker has a 52-week low of $86.68 and a 52-week high of $105.34.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 26th. The medical technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.55 by $0.01. During the same quarter in the prior year, the business earned $1.44 earnings per share. The business earned $2.70 billion during the quarter, compared to analyst estimates of $2.71 billion. The firm’s revenue was up 3.7% compared to the same quarter last year. On average, analysts anticipate that Stryker will post $5.59 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 29th. Stockholders of record on Thursday, December 31st were issued a $0.38 dividend. This is an increase from Stryker’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Tuesday, December 29th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.53%.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

12 Month Chart for NYSE:SYK

Receive News & Ratings for Stryker Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Co. and related companies with MarketBeat.com's FREE daily email newsletter.